top of page

ASTRID PHARMA

The most powerful lifestyle drug delivery system of our time. 

OUR TECHNOLOGY

01 / MODULAR

We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA). 

02 / APPLICABLE

Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues and present multiple epitopes on the surface for vaccine purposes.

03 / RELIABLE

With relatively quick production time and cost, BioCapZ provides an easy-to-store nanoplatform using an icosahedral scaffold for a broad range of therapeutic and theranostic applications. 

Blank canvas template.png
BioCapZ

Modular surface functionalization to carry targeting or tracking peptides, as well as immunogenic peptides for vaccine design. 

We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA). 

Table.png
Product
Male Scientist

BioCapZ

BioCapZ BioCapZ is a protein-based nanoparticle that delivers nucleic acid cargo more effectively than AAVs, Lentivirus, and Polymer-based technologies.

Key benefits:

  • Able to target different tissues

  • Can be dosed orally, i.v, or s.c

  • High drug loading capacity for nucleic acids

  • Doesn't need refrigeration

biocapz_surface.png

The surface of BioCapZ comprises sixty repeating arms that can be decorated with targeting and tracking molecules, as well as immunogenic and therapeutic peptides.

Astrid Pharma Corp. is equipped with state-of-art high-yield production with a highly purified BioCapZ, reducing your cost and time to design and develop a functional capsule tailored to your experimental and commercial needs.

MEET BioCapZ

Proprietary BioCapZ™ platform based on hepatitis E viral capsid for noninvasive diagnostic and targeted therapeutic deliveries.

surface.png
interior.png

The BioCapZ technology was invented by Prof Holland Cheng based on the hepatitis E capsid.  Prof Cheng’s laboratory has engineered the viral capsid to package a wide range of molecules from small molecules to large biological molecules as proteins and nucleic acids (DNA and RNA).  Furthermore, the viral capsid’s surface can be engineered to allow targeted delivery to specific tissues as well as to present multiple epitopes on the surface for vaccine purposes

About

CONSULTATION

Please fill your contact details below:

Thanks for submitting!

Demo
bottom of page